Clinical Trials
9 trialsNCT02766699 2025-06-03
CerebralEDV
Engeneic Pty Limited
Phase 1 Completed
NCT01543763 2025-03-21
Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors
University of California, San Francisco
Phase 1 Completed
NCT02043847 2024-11-13
BMT-03
University of Illinois at Chicago
Phase 1 Completed
NCT02135406 2023-06-22
CART-19 for Multiple Myeloma
University of Pennsylvania
Phase 1 Completed
NCT00272350 2019-12-05
ZD6474 to Treat Advanced Brain Cancer in Patients
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT02189343 2019-11-21
Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Celgene
Phase 1 Completed
NCT02586987 2019-11-18
A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours
AstraZeneca
Phase 1 Completed
NCT01355965 2017-09-19
Autologous Redirected RNA Meso-CIR T Cells
University of Pennsylvania
Phase 1 Completed
NCT01692262 2014-06-19
PYRUS
AstraZeneca
Phase 1 Completed